Hematology and Oncology
Division Faculty
The Sleep and Asthma Cohort (SAC) Study
Lethal Graft-Versus-Host Disease and Survival
Event-Free Survival in Hodgkin Lymphoma
Treatment Pathway of Bone Sarcoma
Silent Infarct Transfusion Study
About the SIT Study
About Sickle Cell Disease
IRB Reporting
UK Consortium Only
Michael R. DeBaun, M.D., M.P.H.
Pediatric Hematology and Oncology Fellowship
Patient Care
Contact Us

An international study aimed at advancing medical care for children with sickle cell disease

The Silent Infarct Transfusion Study (SIT) is an international multi-center clinical study aimed at evaluation of the effectiveness of blood transfusion therapy for silent strokes, a common and serious complication of sickle cell disease.

Silent Infarct Transfusion Study

About the SIT study     About Sickle Cell Disease    For SIT Study members


Vanderbilt University School Of Medicine
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Department of Pediatrics | 2200 Children's Way | Nashville, Tenn. 37232 | 615.936.1000
© 2019 Vanderbilt University School of Medicine
Monroe Carrell Jr. Children's Hospital at Vanderbilt